Detalhe da pesquisa
1.
Stereotactic radiotherapy for managing ovarian cancer oligoprogression under poly (ADP-ribose) polymerase inhibitors (PARPi).
Int J Gynecol Cancer
; 2024 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38821546
2.
Moderate hypofractionation and simultaneous integrated boost by helical tomotherapy in prostate cancer: monoinstitutional report of acute tolerability assessment with different toxicity scales.
Radiol Med
; 120(12): 1170-6, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26002724
3.
Moderate hypofractionated helical tomotherapy for localized prostate cancer: preliminary report of an observational prospective study.
Tumori
; 105(6): 516-523, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31432765
4.
Optimal local control and tolerability of three-dimensional conformal radiation therapy in prostate cancer: a single institutional experience of dose escalation in 125 patients.
Tumori
; 99(6): 676-81, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24503790